Cargando…
Repurposing host-based therapeutics to control coronavirus and influenza virus
The development of highly effective antiviral agents has been a major objective in virology and pharmaceutics. Drug repositioning has emerged as a cost-effective and time-efficient alternative approach to traditional drug discovery and development. This new shift focuses on the repurposing of clinic...
Autores principales: | Li, Cui-Cui, Wang, Xiao-Jia, Wang, Hwa-Chain Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108273/ https://www.ncbi.nlm.nih.gov/pubmed/30711575 http://dx.doi.org/10.1016/j.drudis.2019.01.018 |
Ejemplares similares
-
Host Receptors of Influenza Viruses and Coronaviruses—Molecular Mechanisms of Recognition
por: Sriwilaijaroen, Nongluk, et al.
Publicado: (2020) -
Roles of RNA Sensors in Host Innate Response to Influenza Virus and Coronavirus Infections
por: Li, Wei, et al.
Publicado: (2022) -
Elucidating host cell response pathways and repurposing therapeutics for SARS-CoV-2 and other coronaviruses
por: Shen, Zhewei, et al.
Publicado: (2022) -
Overcoming cancer therapeutic bottleneck by drug repurposing
por: Zhang, Zhe, et al.
Publicado: (2020) -
Cytoplasmic Translocation of Nucleolar Protein NOP53 Promotes Viral Replication by Suppressing Host Defense
por: Meng, Wen, et al.
Publicado: (2018)